Erick Lucera, Chief Financial Officer at Dyne Therapeutics, Inc. (DYN), sold 1,448 shares at $18.36 ($27K) on 2026-05-13, disclosed to the SEC on 2026-05-14.
Scheduled sale ($27k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DYN | SELL | 2026-04-03 | $107K | — | Filing → |
| EDIT | SELL | 2025-03-05 | $7K | — | Filing → |
| XAIR | BUY | 2024-08-15 | $16K | — | Filing → |